A global leader in the field of life science and clinical research cloud solution provider, today announced that Medidata, the company with the world's leading research-based pharmaceutical and healthcare company GlaxoSmithKline co-sponsored mobile medical plan, the first clinical study in Excellence (CARE) Awards The ceremony was named "Best Clinical Partner of the Year" in 2016.

Medidata and GlaxoSmithKline's collaborative development program evaluate the impact of integrating mobile medical devices with cloud technology in a clinical trial environment. The collaboration opens up a leading way to revolutionize drug development, making trials more efficient, identifying “digital biomarkers” and providing deeper insights into treatment efficiency and patient health.

Julian Jenkins, Vice President, Innovation, Performance and Technology, GlaxoSmithKline, said: "We believe that this type of technology can help us better understand the patient's response to the drug without increasing the burden on the clinical trial participants. Meet the needs of patients aptly."

The CARE Awards are hosted by Pharma Intelligence, a leading global provider of clinical research information and analysis under Informa, which also includes leading brands such as Scrip Intelligence, In Vivo and Pink Sheet. The award recognizes excellence and innovation in the biopharmaceutical industry and ongoing efforts to improve the global healthcare sector. The jury, composed of independent industry experts from around the world, presented the award to Medidata and GlaxoSmithKline at the awards ceremony in Boston.

By collecting 18 million data points from each subject's daily activities and vital signs, Medidata and GlaxoSmithKline show that mobile medical technology can comprehensively collect a large number of objective data that are reliable, safe and analyzable, and target patients. The physical condition provides real-time, continuous observation.

Mr. Mike Capone, Chief Operating Officer of Medidata, said: "Our partnership with GlaxoSmithKline has a shared vision of how mobile healthcare technology can fundamentally transform the way we conduct clinical research, improve patient engagement and accelerate drug development. Innovation. By integrating mobile medical devices with the Medidata Clinical Cloud, we have proven that this technology can safely and effectively provide diagnostic equipment to patients, collect objective, high-quality information, and collect rich, new data. ”

Medidata and GlaxoSmithKline offer two wearable devices for project research. Vital Connect's HealthPatch MD and ActiGraph's wGT3X-BT Monitor continuously measure vital signs, ECG data and activity levels. In addition, the research team also used a mobile application software, Medidata Patient Cloud ePRO (electronic patient report results) provided by Medidata's industry-leading technology platform. The researchers collected data from mobile medical devices by carrying smartphones, imported the data into the Medidata Clinical Cloud platform, and mapped them into clinical records. The subjects' daily lives were not affected, and they were only signed at GlaxoSmithKline's Human Performance Lab platform at the beginning and end of the project.

Mr. Capone added: “As we continue to work with GlaxoSmithKline to obtain meaningful insights from these data, we foresee that mobile medical research will become the standard of practice in the future, and clinical trials will become faster, cheaper and more Patient-centric. We are committed to laying the foundation for life science companies to help them explore the exciting possibilities of mobile healthcare – including better decision making, better trial results, and ultimately better patient care. Therefore, we are proud to receive this industry award from Informa."

In addition to the “Best Clinical Partner of the Year” award, Medidata's MOVE study also entered the “Best Patient-Oriented Technology Development” category. In this behavioral study, Medidata tested whether mobile medical tools could be used in overweight adults with type 2 diabetes to achieve better medical outcomes. This pilot open clinical trial is an important step for Medidata to work under the influence of operational, technical and regulatory efforts to integrate mobile medical devices and tools into clinical trials and ultimately to develop a new model for drug development for faster research And meet patient needs at a lower cost.

Wetness Indicator Adult Diaper

Adult diapers are disposable urinary incontinence products, one of the adult care products, and a disposable diaper mainly suitable for incontinent adults.
Most products are flaky and shorts type. Use adhesive sheets to connect into a pair of shorts. The adhesive sheet also has the function of adjusting the waist size so as to fit different fat and thin body shapes.
Generally, the structure of diapers is divided into three layers from the inside to the outside. The inner layer is close to the skin and made of non-woven fabric; the middle layer is water-absorbent fluff pulp, added with polymer water-absorbing agent; the outer layer is an impermeable breathable film.

Tena Diapers,Adult Nappies,Adult Underpads,Adult Pull Up Diaper

Shandong Kangshun Daily Products Co., Ltd , https://www.centurybenifit.com